Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.48 |
| ▸ | NOS1 | P29475 | 2/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | NOS2 | P35228 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10690050 | 0.98 | IDO1 (0.50) | IDO1NOS1NOS3NOS2CYP2C19 | |
| SCHEMBL27639758 | 0.89 | LMNA (0.47) | ALDH1A1HPGDLMNAMEN1KMT2A | |
| SCHEMBL3063086 | 0.85 | IDO1 (0.43) | IDO1NOS1NOS3NOS2CYP2C19 | |
| SCHEMBL27660548 | 0.85 | AOC3 (0.50) | — | |
| SCHEMBL3078872 | 0.85 | IDO1 (0.46) | IDO1NOS1NOS3NOS2CYP2C19 | |
| SCHEMBL3080810 | 0.83 | CYP2C19 (0.47) | IDO1NOS1NOS3NOS2CYP2C19 | |
| SCHEMBL7844886 | 0.83 | SMN1; SMN2 (0.47) | IDO1NOS1NOS3NOS2CYP2C19 | |
| SCHEMBL3057987 | 0.83 | IDO1 (0.44) | IDO1NOS1NOS3NOS2CYP2C19 | |
| SCHEMBL13734757 | 0.82 | NOS1 (0.48) | NOS1CYP2C19ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL27953297 | 0.82 | NOS1 (0.42) | IDO1NOS1ALDH1A1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106084714-A | A kind of agricultural mulching and preparation method thereof | 吉林省农业科学院 | 2016-11-09 | — | — | CN | claimed |
| EP-1716197-B1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF SE (DE) | 2008-10-29 | — | — | EP | claimed |
| CN-100387320-C | Chelation type hollow fiber affinity membrane chromatogram, its manufacturing method and use | UNIV TIANJIN POLYTECHNIC (CN) | 2008-05-14 | — | — | CN | claimed |
| CN-1768893-A | Chelation type hollow fiber affinity membrane chromatogram, its manufacturing method and use | UNIV TIANJIN POLYTECHNIC (CN) | 2006-05-10 | — | — | CN | claimed |
| US-20250092020-A1 | IDO/TDO Inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-03-20 | — | — | US | disclosed |
| US-12209079-B2 | IDO/TDO inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-01-28 | — | — | US | disclosed |
| CN-119192087-A | Chemical synthesis method of ergothioneine | 镇江卡博医药科技有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20220380305-A1 | IDO/TDO Inhibitor | CANBAS CO., LTD. | 2022-12-01 | — | — | US | disclosed |
| US-20200239452-A1 | IDO/TDO Inhibitor | CANBAS CO., LTD. (JP) | 2020-07-30 | — | — | US | disclosed |
| WO-2019078246-A1 | IDO/TDO INHIBITOR | 一般社団法人ファルマバレープロジェクト支援機構 | 2019-04-25 | — | — | WO | disclosed |
| CN-108743446-A | A kind of ultrafiltration membrane preparation method of cocoon sericin protein and its application | 中国科学院新疆理化技术研究所 | 2018-11-06 | — | — | CN | disclosed |
| CN-107582588-A | A kind of purposes of the white phoenix dish extractive of general flavone and preparation method thereof with treating alcoholic fatty liver | 漳州片仔癀药业股份有限公司 | 2018-01-16 | — | — | CN | disclosed |
| US-6933304-B2 | Heteroarylalkanoic acids as integrin receptor antagonists | PHARMACIA CORPORATION (US) | 2005-08-23 | — | — | US | disclosed |
| CN-1589153-A | Prevention or treatment of urinary disorders | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2005-03-02 | — | — | CN | disclosed |
| US-20040092497-A1 | Heteroarylakanoic acids as intergrin receptor antagonists | PHARMACIA CORPORATION | 2004-05-13 | — | — | US | disclosed |
| CN-1117754-C | Indolomorphinane derivatives and remedies/preventives for cerebral disorders | TORAY INDUSTRIES (JP) | 2003-08-13 | — | — | CN | disclosed |
| EP-1289983-A2 | HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS | Pharmacia Corporation (US) | 2003-03-12 | — | — | EP | disclosed |
| US-20020133023-A1 | Heteroarylalkanoic acids as integrin receptor antagonists | PHARMACIA CORPORATION | 2002-09-19 | — | — | US | disclosed |
| WO-2001096334-A2 | HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS | PHARMACIA CORPORATION (US) | 2001-12-20 | — | — | WO | disclosed |
| CN-1220668-A | INDOLOMORPHINANE DERIVATIVES AND REMEDIES/PREVENTIVES FOR CEREBRAL DISORDERS | TORAY INDUSTRIES (JP) | 1999-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12209079-B2 | IDO/TDO inhibitor | IDO1, IDO2, TDO2 | IDO1 1/4885NOS1 233/4885NOS3 494/4885 |
| US-20020133023-A1 | Heteroarylalkanoic acids as integrin receptor antagonists | ITGA5, ITGA2B, ITGAV | IDO1 3607/4885NOS1 4741/4885NOS3 4391/4885 |
| US-20040092497-A1 | Heteroarylakanoic acids as intergrin receptor antagonists | ITGA5, ITGB7, ITGA2B | IDO1 2548/4885NOS1 4111/4885NOS3 3632/4885 |
| US-20200239452-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | IDO1 1/4885NOS1 233/4885NOS3 494/4885 |
| US-20250092020-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | IDO1 1/4885NOS1 233/4885NOS3 494/4885 |
| US-20220380305-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | IDO1 1/4885NOS1 174/4885NOS3 438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.